PATENT CLAIM ANALYSIS

Application Number: 15761964
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed are methods for modulating splicing of Ataxin 3 mRNA in an animal with modified oligonucleotides. Such compounds and methods are useful to treat, prevent, or ameliorate spinocerebellar ataxia type 3 (SCA3) in an individual in need thereof.

Claim (Index 46):
The oligomeric compound of  claim 45 , wherein the modified oligonucleotide comprises at least one nucleoside comprising a modified sugar moiety.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15835995', '15835698', '15045999', '14009782', '14168812']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7913213717243034
- 35 USC 102 Novelty (BERT): 0.5677752257735996
- Combined Prediction Score: 0.7689667571292331
- Mean Citation Score: 448.29097
- Max Citation Score: 459.91348
- Similarity Product: 358.1396133189201

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test